👏👏👏👏👏👏 #Emna_Mahfoudi, @C_Ricordel and team -- Preclinical Models for Acquired Resistance to Third-Generation EGFR Inhibitors in NSCLC: Functional Studies and Drug Combinations Used to Overcome Resistance

RT @FEBSJournal: 🔔Here is another exciting #EditorProfile where our Editorial Board member Eric Chevet @Eric_Chevet @Eugene_Marquis @Inserm…

Latest review from the lab @InsermGrdOuest @Eugene_Marquis on "Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases" by Vesna Risso, @lafont_elodie and @MattLeGallo. Read it here:

#InternationalWomansDay2022 @CSignaling @UnivRennes1 @InsermGrdOuest https://t.co/T3ThWyKDMn

same here 💪 @MarciniakLab #WeStandWithUkraine 🇺🇦

RT @Biosit2: Depuis le 1er Janvier 2022, @CharlesPineau (Dir de @Biosit2) est le nouveau président du Human Proteome Project. Le HPP lance…

RT @lafont_elodie: Glad to share our latest work linking IRE1 and CD95 signalling. By @DianaPelizzari @MattLeGallo Raphael Pineau @AlexPapa…

RT @Eric_Chevet: Communauté scientifique : Soutien aux chercheurs et étudiants en Ukraine via @ChangeFrance

👏👏👏👏👏@SophieM82438474 and @avril_tony A cell-based system combined with flow cytometry to evaluate antibody ...

👏👏👏👏👏 Astrid!!! poke @CoulouarnC Patient healthcare trajectories of intrahepatic cholangiocarcinoma in ...